-41.1%
ACN vs BBIO
+42.7%
-83.9%
-68.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 5y.
| Period | Portfolio | BBIO | Excess | Alpha |
|---|---|---|---|---|
| 1D | +3.4% | -0.1% | +3.4% | +3.4% |
| 7D | -1.5% | -3.2% | +1.7% | -1.3% |
| 30D | +2.1% | -13.6% | +15.7% | +2.9% |
| 3M | +11.1% | +7.2% | +3.9% | +10.6% |
| 6M | -6.8% | +1.5% | -8.3% | -7.1% |
| YTD | -30.0% | -5.3% | -24.8% | -30.1% |
| 1Y | -23.1% | +37.7% | -60.8% | -25.0% |
| 3Y | -40.4% | +153.9% | -194.3% | -44.7% |
| All | -41.1% | +42.7% | -83.9% | -52.6% |
Cumulative growth
Daily Returns
Daily percentage return beside BBIO.
Daily Out/Under-Performance
Portfolio return minus BBIO return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × BBIO return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 5y: compounded portfolio wealth divided by compounded BBIO wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
5y analysis · Full analysis span regression · 6 months rolling